AB0024 Systemic inflammation and b-cells in rheumatoid arthritis
Background Rheumatoid arthritis (RA) is heterogeneous in clinical symptoms, clinical parameters, pathogenesis and gene expression levels. Previously, we demonstrated variation in B-cell related gene expression between RA patients. Objectives The aim was to explore the relation of B-cell related gene...
Saved in:
Published in | Annals of the rheumatic diseases Vol. 72; no. Suppl 3; p. A793 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BMJ Publishing Group Ltd and European League Against Rheumatism
01.06.2013
BMJ Publishing Group LTD |
Online Access | Get full text |
Cover
Loading…
Summary: | Background Rheumatoid arthritis (RA) is heterogeneous in clinical symptoms, clinical parameters, pathogenesis and gene expression levels. Previously, we demonstrated variation in B-cell related gene expression between RA patients. Objectives The aim was to explore the relation of B-cell related gene expression to clinical parameters of disease severity in early arthritis (EA) and established RA (esRA). Methods B-cell related gene expression (B-cell score) was determined in peripheral blood cells of 26 EA and 180 esRA patients, using multiplex real-time PCR. For the EA cohort, B-cell counts were also measured using flow cytometry. The esRA cohort was (randomly) divided into test and validation group of each 90 RA patients, with a mean DAS28 of 5.0 and 5.2, respectively. Associations were assessed between B-cell scores and the clinical disease parameters DAS28, CRP, RF, anti-CCP, nodules and erosions in all cohorts and B-cell counts only in EA cohort. Statistical testing was executed according to a bootstrap method which randomizes the esRA group a 1000 times into two equally sized groups. Results We demonstrated that the B-cell score reflected the peripheral blood B-cell count (p<0.0001, r=0.7463). In EA, the B-cell score revealed a significant negative correlation with CRP levels (p=0.0137; r=-0.4773). In the esRA group we also observed a negative correlation between the B-cell score and CRP levels (p=0.0004, r=-0.3666). This result was confirmed in the independent validationgroup (p=0.0194; r=-0.2461). Additionally, we performed a randomization with the bootstrap method, which showed the same significant correlations in almost all cases. However, no correlations were found between B-cell score and DAS28, RF, anti-CCP, nodules or erosions. Conclusions The B-cell score reflects the B-cell count in RA and a low B-cell count is associated with an increased marker of systemic inflammation in RA. Disclosure of Interest None Declared |
---|---|
Bibliography: | ark:/67375/NVC-H3S4KCSG-L href:annrheumdis-72-A793-1.pdf ArticleID:annrheumdis-2013-eular.2347 local:annrheumdis;72/Suppl_3/A793-a istex:C1D0B5F2C53F32607C68067783D6C1E7ED1E266D |
ISSN: | 0003-4967 1468-2060 |
DOI: | 10.1136/annrheumdis-2013-eular.2347 |